AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36400394 — intervention group
Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (control group) for cervical spine patients
Number of subjects: 236
Study 33836985 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer social support group intervention using the CARES skills framework
Number of subjects: 78
Study 33836985 — intervention group
Group type: COMPARATOR
Intervention: Control group (second year students)
Number of subjects: 78
Study 33836985 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer social support group intervention
Number of subjects: 78
Study 32787953 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Note Scoring rubric (PNS)
Number of subjects: 235
Study 32787953 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Reasoning Task (CRT)
Number of subjects: 235
Study 32787953 — intervention group
Group type: COMPARATOR
Intervention: Clinical Data Interpretation (CDI)
Number of subjects: 235
Study 32787953 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary Statement Assessment Rubric (SSAR)
Number of subjects: 235
Study 35080051 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 220
Study 35080051 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 220
Study 33398890 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (2 doses taken as a split dose with a meal)
Number of subjects: 0
Study 33398890 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine–pyrimethamine (4 doses)
Number of subjects: 0
Study 35329896 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame intervention (20 minutes, twice per week)
Number of subjects: 58
Study 35329896 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physical education classes only)
Number of subjects: 58
Study 32499254 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus KOMPACT (2 hours 20 minutes of preoperative physiotherapy informed by Acceptance and Commitment Therapy)
Number of subjects: 51
Study 32499254 — intervention group
Group type: COMPARATOR
Intervention: Usual care (education class)
Number of subjects: 51
Study 32603873 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Concepts Questionnaire (PCQ)
Number of subjects: 0
Study 33070288 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib 300 mg in fasted state
Number of subjects: 0
Study 33070288 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib in fed state
Number of subjects: 0
Study 33070288 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine in fasted state
Number of subjects: 0
Study 33070288 — intervention group
Group type: COMPARATOR
Intervention: Pivotal clinical formulation (PCF) and commercial formulation (CF)
Number of subjects: 0
Study 33571645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography scans
Number of subjects: 100
Study 32921505 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Concerns Inventory (PCI)
Number of subjects: 288
Study 32921505 — intervention group
Group type: COMPARATOR
Intervention: Non-PCI
Number of subjects: 288
Study 36271804 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 36271804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32857331 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days antibiotics
Number of subjects: 96
Study 32857331 — intervention group
Group type: COMPARATOR
Intervention: 10 days antibiotics
Number of subjects: 96
Study 32427125 — intervention group
Group type: EXPERIMENTAL
Intervention: Kapalbhathi pranayama (5 minutes)
Number of subjects: 50
Study 32427125 — intervention group
Group type: COMPARATOR
Intervention: Normal breathing (control group)
Number of subjects: 50
Study 34605713 — intervention group
Group type: EXPERIMENTAL
Intervention: Report cards featuring salient information about donor organ utilization rates
Number of subjects: 2038
Study 34605713 — intervention group
Group type: EXPERIMENTAL
Intervention: Report cards featuring overall survival rates
Number of subjects: 2038
Study 34605713 — intervention group
Group type: COMPARATOR
Intervention: Conservative donor acceptance strategy
Number of subjects: 2038
Study 33903925 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA)
Number of subjects: 0
Study 35694051 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-guided imagery
Number of subjects: 30
Study 35694051 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33274215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian preservation
Number of subjects: 281
Study 33274215 — intervention group
Group type: COMPARATOR
Intervention: Nonovarian preservation
Number of subjects: 281
Study 35556238 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM)
Number of subjects: 38
Study 35556238 — intervention group
Group type: COMPARATOR
Intervention: Placebo Therapeutic Ultrasound (US)
Number of subjects: 38
Study 35556238 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 33658407 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel‐sealing liquid (Tiefenfluorid)
Number of subjects: 36
Study 33658407 — intervention group
Group type: EXPERIMENTAL
Intervention: FluoroLux
Number of subjects: 36
Study 33658407 — intervention group
Group type: EXPERIMENTAL
Intervention: InnoDent
Number of subjects: 36
Study 33658407 — intervention group
Group type: EXPERIMENTAL
Intervention: ClinproTM XT Varnish
Number of subjects: 36
Study 616473919 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training for plantar flexors performed using an isokinetic dynamometer, 3 times a week for 8 weeks
Number of subjects: 24
Study 616473919 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 24
Study 36129266 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclamptic pregnant women (Group 1)
Number of subjects: 150
Study 36129266 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclamptic pregnant women (Group 3)
Number of subjects: 150
Study 34151493 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (3 mg/kg/day) for 4 months
Number of subjects: 50
Study 34151493 — intervention group
Group type: COMPARATOR
Intervention: Oral dexamethasone mini pulse (2.5 mg dexamethasone on two consecutive days/week for 4 months)
Number of subjects: 50
Study 32700655 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg oral daily (group RXE)
Number of subjects: 160
Study 32700655 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 IU/day subcutaneously for 14 days (group ENO)
Number of subjects: 160
Study 36070255 — intervention group
Group type: EXPERIMENTAL
Intervention: Spending money on someone else
Number of subjects: 133
Study 36070255 — intervention group
Group type: COMPARATOR
Intervention: Spending money on oneself
Number of subjects: 133
Study 36070255 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct measure of happiness when spending money on someone else
Number of subjects: 133
Study 34302514 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% capsaicin treatment
Number of subjects: 18
Study 32673877 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Advocate (PA) intervention for 6 months
Number of subjects: 312
Study 32673877 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 312
Study 32772049 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized medicine based on human genetics for cardiovascular diseases
Number of subjects: 0
Study 32772049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies examining loss-of-function genetic variations
Number of subjects: 0
Study 32270774 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day low residue diet (LRD)
Number of subjects: 0
Study 32270774 — intervention group
Group type: COMPARATOR
Intervention: 2-day low residue diet (LRD)
Number of subjects: 0
Study 34724045 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid administration
Number of subjects: 973
Study 34724045 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid administration
Number of subjects: 973
Study 33254172 — intervention group
Group type: EXPERIMENTAL
Intervention: Asleep deep brain stimulation (DBS) under general anesthesia without microelectrode recordings (MER) (20 patients)
Number of subjects: 29
Study 33254172 — intervention group
Group type: COMPARATOR
Intervention: Awake deep brain stimulation (DBS) under local anesthesia with MER (9 patients)
Number of subjects: 29
Study 35521789 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (1 mg s.c. injection)
Number of subjects: 42
Study 35521789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 35521789 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin cut-off level of 4.6 pmol/L
Number of subjects: 42
Study 32125619 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with deqi
Number of subjects: 70
Study 32125619 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture without deqi
Number of subjects: 70
Study 34727808 — intervention group
Group type: EXPERIMENTAL
Intervention: Community capacity‐building intervention
Number of subjects: 241
Study 34727808 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 241
Study 34927195 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA supplementation
Number of subjects: 736
Study 33150384 — intervention group
Group type: COMPARATOR
Intervention: Rurioctocog alfa pegol prophylaxis targeting FVIII troughs of 1% to 3% (reference arm)
Number of subjects: 115
Study 33150384 — intervention group
Group type: EXPERIMENTAL
Intervention: Rurioctocog alfa pegol prophylaxis targeting FVIII troughs of 8% to 12% (elevated arm)
Number of subjects: 115
Study 32633196 — intervention group
Group type: EXPERIMENTAL
Intervention: Postradiation swallowing evaluation
Number of subjects: 168
Study 35595747 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day standardized Mediterranean diet (MedDiet)
Number of subjects: 7
Study 35595747 — intervention group
Group type: COMPARATOR
Intervention: Control diet inspired by Canadian macronutrient intake (CanDiet)
Number of subjects: 7
Study 33189891 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 33189891 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study 33189891 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 0
Study 33189891 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir
Number of subjects: 0
Study 32507136 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian current group (RCG)
Number of subjects: 23
Study 32507136 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 23
Study 32507136 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study 33307546 — intervention group
Group type: EXPERIMENTAL
Intervention: GenOMICC genome-wide association study
Number of subjects: 2244
Study 33307546 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 2244
Study 33307546 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association in lung tissue
Number of subjects: 2244
Study 32424022 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-processed whole grains
Number of subjects: 31
Study 32424022 — intervention group
Group type: COMPARATOR
Intervention: Finely milled grains
Number of subjects: 31
Study 36308110 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral lidocaine hydrochloride 1% and tropicamide injection 0.02%
Number of subjects: 32
Study 34714539 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (0.3 mL/kg of 0.25 percent bupivacaine, fentanyl 50 µg, and naloxone 100 ng)
Number of subjects: 135
Study 34714539 — intervention group
Group type: COMPARATOR
Intervention: Group I (0.3 mL/kg of 0.25 percent bupivacaine)
Number of subjects: 135
Study 34714539 — intervention group
Group type: COMPARATOR
Intervention: Group III (0.3 mL/kg of 0.25 percent bupivacaine and fentanyl 50 µg)
Number of subjects: 135
Study 36175722 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic therapy prior to surgery
Number of subjects: 65
Study 36175722 — intervention group
Group type: COMPARATOR
Intervention: Control group (no biologic therapy)
Number of subjects: 65
Study 35170726 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency-assisted liposuction (RFAL; Group A)
Number of subjects: 176
Study 35170726 — intervention group
Group type: EXPERIMENTAL
Intervention: Renuvion helium subdermal coagulation (Group B)
Number of subjects: 176
Study 35170726 — intervention group
Group type: COMPARATOR
Intervention: VASER-assisted liposuction (VAL) alone (Group C)
Number of subjects: 176
Study 35170726 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction as assessed by an independent plastic surgeon
Number of subjects: 176
Study 32282787 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel bone conduction hearing aid system
Number of subjects: 12
Study 32282787 — intervention group
Group type: COMPARATOR
Intervention: BCHA headband system
Number of subjects: 12
Study 36192602 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training intervention (five sessions, online)
Number of subjects: 0
Study 36192602 — intervention group
Group type: COMPARATOR
Intervention: Practice group (repeatedly performed the same vWM task)
Number of subjects: 0
Study 36192602 — intervention group
Group type: COMPARATOR
Intervention: Passive group (test-retest effects)
Number of subjects: 0
Study 34137476 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (up to 300 mg)
Number of subjects: 29
Study 34137476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 32498637 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming training program (Xbox 360 Kinect™; 20 sessions, 2-3 times per week)
Number of subjects: 45
Study 32498637 — intervention group
Group type: COMPARATOR
Intervention: Control group (volunteers without a cancer diagnosis; n=15)
Number of subjects: 45
Study 33856638 — intervention group
Group type: EXPERIMENTAL
Intervention: pembrolizumab plus pomalidomide and dexamethasone (n = 15)
Number of subjects: 27
Study 33856638 — intervention group
Group type: COMPARATOR
Intervention: pomalidomide and dexamethasone alone (n = 12)
Number of subjects: 27
Study 32940419 — intervention group
Group type: EXPERIMENTAL
Intervention: HIRREM (linked to brainwaves)
Number of subjects: 107
Study 32940419 — intervention group
Group type: COMPARATOR
Intervention: Random tones (sham control)
Number of subjects: 107
Study 32940419 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIRREM and Random tones
Number of subjects: 107
Study 34186201 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual chewing on the affected side
Number of subjects: 24
Study 34186201 — intervention group
Group type: EXPERIMENTAL
Intervention: Condylar path angle on the affected side
Number of subjects: 24
Study 34186201 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral guidance angles on the affected side
Number of subjects: 24
Study 32388857 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual module
Number of subjects: 32
Study 32388857 — intervention group
Group type: COMPARATOR
Intervention: Traditional instructional module
Number of subjects: 32
Study 36244879 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose influenza vaccine (HD)
Number of subjects: 823
Study 36244879 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose influenza vaccine (SD)
Number of subjects: 823
Study 33769732 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (0.3 mg/kg/week)
Number of subjects: 133
Study 33769732 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Methotrexate (0.15 mg/kg/week) and Cyclosporine (2.5 mg/kg/day)
Number of subjects: 133
Study 33944974 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp reminders (W)
Number of subjects: 54
Study 33944974 — intervention group
Group type: EXPERIMENTAL
Intervention: Email reminders (E)
Number of subjects: 54
Study 33944974 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 54
Study 32319791 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Insulin Delivery (AID)
Number of subjects: 10
Study 32319791 — intervention group
Group type: COMPARATOR
Intervention: Conventional Therapy
Number of subjects: 10
Study 33742652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 1124
Study 33742652 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1124
Study 33742652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1124
Study 33742652 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Cohort (Tofacitinib 5 mg or 10 mg BID)
Number of subjects: 1124
Study 34726472 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Pilates (CLP)
Number of subjects: 40
Study 34726472 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (COP)
Number of subjects: 40
Study 34715718 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorus 30cH
Number of subjects: 20000
Study 34715718 — intervention group
Group type: EXPERIMENTAL
Intervention: Bryonia alba 30cH
Number of subjects: 20000
Study 34715718 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelsemium sempervirens 30cH
Number of subjects: 20000
Study 34715718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20000
Study 34450326 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equation (GEE) approach for sample size estimation
Number of subjects: 0
Study 34450326 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-form sample size and power formulas for LCRTs and CCRTs
Number of subjects: 0
Study 35834624 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation (nitrate-rich beetroot juice)
Number of subjects: 26
Study 33099307 — intervention group
Group type: EXPERIMENTAL
Intervention: Female GPs
Number of subjects: 3755
Study 33099307 — intervention group
Group type: EXPERIMENTAL
Intervention: Practices in more deprived areas
Number of subjects: 3755
Study 33099307 — intervention group
Group type: EXPERIMENTAL
Intervention: Main urban centre practices
Number of subjects: 3755
Study 34196141 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (part of a placebo-controlled randomized clinical trial)
Number of subjects: 67
Study 35568602 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) supplemented by usual care (2 in-person and 4 follow-up phone calls with a nurse educator)
Number of subjects: 66
Study 35568602 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) supplemented by usual care
Number of subjects: 66
Study 35568602 — intervention group
Group type: COMPARATOR
Intervention: Usual care (every 3 months visit with pediatric endocrinologist)
Number of subjects: 66
Study 35568602 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study 32711528 — intervention group
Group type: EXPERIMENTAL
Intervention: InConnection approach
Number of subjects: 300
Study 32711528 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 300
Study 36112172 — intervention group
Group type: COMPARATOR
Intervention: Non-spatial secondary task (arithmetic)
Number of subjects: 87
Study 36112172 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no secondary task)
Number of subjects: 87
Study 36112172 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial secondary task (star movement)
Number of subjects: 87
Study 36112172 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay duration (20 s, 60 s)
Number of subjects: 87
Study 32029126 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 1023
Study 32029126 — intervention group
Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 1023
Study 35451096 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine assessment of orthostatic hypotension (OH)
Number of subjects: 534
Study 35451096 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated assessment of orthostatic hypotension (OH)
Number of subjects: 534
Study 32289841 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight load
Number of subjects: 31
Study 32289841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean body mass load
Number of subjects: 31
Study 34756489 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) on flexor carpi ulnaris (FCU)
Number of subjects: 72
Study 34756489 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) on extensor carpi radialis brevis and longus (ECRB/L)
Number of subjects: 72
Study 34756489 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping (PT) on flexor carpi ulnaris (FCU)
Number of subjects: 72
Study 34756489 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping (PT) on extensor carpi radialis brevis and longus (ECRB/L)
Number of subjects: 72
Study 34756489 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 72
Study 33605765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancilla-free experimental scheme for the measurement of many-body Chern number (MBCN) using statistical correlations of randomized measurements
Number of subjects: 0
Study 33605765 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical correlations of randomized measurements
Number of subjects: 0
Study 35807160 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.1% fluorometholone combined with 0.05% azelastine
Number of subjects: 111
Study 35807160 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.1% fluorometholone alone
Number of subjects: 111
Study 35807160 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (combination and isolated fluorometholone)
Number of subjects: 111
Study 33127993 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium administration
Number of subjects: 37
Study 33127993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 34781788 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drinks targeting a BAC of 0.05%
Number of subjects: 60
Study 34781788 — intervention group
Group type: COMPARATOR
Intervention: Placebo drinks
Number of subjects: 60